Morningside BioPharma Advisory | 686 followers on LinkedIn. Morningside BioPharma Advisory is a biopharmaceutical incubator aiming to bring innovative therapies rapidly to market | Morningside Biopharma Advisory (MBA) is a biopharmaceutical incubator that brings innovative therapies rapidly to market by building a portfolio of companies around prototype assets focused on infection, immunity, and inflammation. MBA is backed by Morningside Ventures, who have established an enviable reputation over its several decades of existence as an independently-minded, science-focused, life sciences investor. During the past several years, Morningside has advanced some of its portfolio build through the shared services of MBA under the leadership of its internal team of highly experienced biopharma executives and entrepreneurs.
View Top Employees from Morningside BioPharma Advisory| Employees | 3 (3 on RocketReach) |
| Industry | Biotechnology |
Looking for a particular Morningside BioPharma Advisory employee's phone or email?
Morningside BioPharma Advisory Questions
Laurent Chesnel is the Vice President Research and Development of Morningside BioPharma Advisory.
3 people are employed at Morningside BioPharma Advisory.
Top Morningside BioPharma Advisory Employees
-
ViewMegan Quintas
Senior Clinical Trial Manager at Morningside BioPharma Advisory
Voluntown, Connecticut, United States32
Related Companies
